HIIFS
QTTB icon

Harel Insurance Investments & Financial Services’s Q32 Bio QTTB Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-556
Closed -$314K – 883
2021
Q1 		$314K Hold
556
– – 0.01% 547
2020
Q4 		$363K Buy
+556
New +$107K 0.01% 407

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Harel Insurance Investments & Financial Services's QTTB Position: Q2 2021 in Review

Harel Insurance Investments & Financial Services sold out of Q32 Bio (QTTB) in Q2 2021, closing a stake of 556 shares — an estimated $314K sold.

Harel Insurance Investments & Financial Services first reported a position in QTTB in Q4 2020 and held it in 2 quarters. The position peaked at $363K in Q4 2020. 118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Q32 Bio position as of Q2 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 556 Q32 Bio shares in Q2 2021, an estimated $314K.
  • Harel Insurance Investments & Financial Services first reported a position in Q32 Bio in Q4 2020 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Q32 Bio position peaked at $363K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2021, filed 26 Jul 2021.